A new chapter in oncology care for India's Northeast opened on Saturday, 31 October 2026, when Assam Chief Minister Himanta Biswa Sarma announced the signing of an agreement to establish a Proton Beam Therapy Centre in Guwahati — a move that could fundamentally alter where cancer patients from the region go for treatment.

What proton therapy means for Northeast cancer patients

Proton beam therapy is among the most precise forms of radiation oncology available today. Unlike conventional radiotherapy, which deposits energy as beams pass through the body, proton therapy delivers the bulk of its dose directly at the tumour — sparing surrounding healthy tissue, reducing side effects, and making it especially valuable for paediatric cancers and tumours near critical structures like the brain or spine.

For decades, patients in Assam and neighbouring Northeast states requiring this level of care had little choice but to travel thousands of kilometres to cities like Chennai or Mumbai — a financial and logistical burden that often delayed or disrupted treatment. A facility anchored in Guwahati, the region's largest city, changes that calculus entirely.

Guwahati's growing role as a medical hub

Guwahati has steadily emerged as the Northeast's premier destination for advanced medical care. The city already hosts an AIIMS campus, and the Assam government has, since 2016, pushed successive rounds of investment in new medical colleges and super-specialty blocks under state health missions — each intended to reduce the region's dependence on distant metros.

The proton therapy centre, if realised on schedule, would represent the single most technologically sophisticated addition to that infrastructure yet. Proton beam facilities demand not only capital-intensive cyclotron or synchrotron equipment but a rare cohort of trained medical physicists and radiation oncologists — making the recruitment and training pipeline a critical variable to watch alongside civil works and equipment procurement.

Where Assam fits in India's proton therapy map

India has moved cautiously on proton therapy infrastructure. Existing or planned centres have largely been concentrated in Maharashtra and Tamil Nadu — states with deeper private-sector healthcare ecosystems. The Guwahati agreement, if it proceeds, would mark a deliberate push to extend that frontier into a part of the country that has historically been underserved by super-specialty oncology.

National cancer control programmes have increasingly flagged the Northeast as a priority zone, given the region's elevated incidence of certain cancers — particularly those linked to tobacco and dietary risk factors. State-level investment of this scale, paired with potential central support, could meaningfully reduce outward patient migration from Assam, Meghalaya, Nagaland, Manipur and beyond.

The details that matter most now — the agreement partners, funding architecture, equipment timelines, and when the first patient might walk through those doors — remain to be officially disclosed. But the direction is unmistakable. Guwahati is being built into a place where the Northeast's most complex cancer cases stay home.